Suppr超能文献

舌下特异性免疫疗法对合并或不合并变应性鼻炎的哮喘儿童肺功能和呼出气一氧化氮水平的影响。

Effects of sublingual-specific immunotherapy on pulmonary function and exhaled nitric oxide levels in asthmatic children with and without allergic rhinitis.

作者信息

Ai Tao, Wang Li, Luo Ronghua, Fan Yinghong, Liao Huiling, Xia Wanmin, Zhang Lei, Duan Yaping

机构信息

Department of Pediatric Respiratory Medicine, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

出版信息

Transl Pediatr. 2020 Oct;9(5):686-694. doi: 10.21037/tp-20-322.

Abstract

BACKGROUND

Allergic asthma and allergic rhinitis are common chronic respiratory diseases in children. The prevalence rate of disease is increasing year by year. And avoid allergens, drug treatments and special immunotherapy (SIT) is the fundamental treatment for respiratory allergies diseases. But there are few comprehensive studies on the control level of asthma, improvement of lung function, and changes of exhaled nitric oxide (FeNO) after SLIT treatment in children with allergic asthma and rhinitis.

METHODS

In all, 71 child asthma patients who received sublingual-specific immune therapy for 1 year or more were divided into an asthmatic rhinitis group (31 cases) and an asthma-alone group (40 cases). The two groups of patients were compared before and after treatment in terms of rhinitis symptom scores, daytime and nighttime asthma symptom scores, visual analog scale (VAS) score, drug score, pulmonary function, and exhaled nitric oxide level (FeNO).

RESULTS

After treatment, daytime symptom scores, VAS scores, drug scores, and FeNO levels of the asthma-alone group were all lower than before treatment, and the lung function was significantly improved (P<0.05), while the difference in night symptom scores before and after treatment was not statistically significant (P>0.05). The lung function and FeNO level of children in the asthmatic rhinitis group were lower after treatment than before treatment, with statistically significant differences (P<0.05). The scores of rhinitis and VAS in the asthmatic rhinitis group were higher than those in the asthma-alone group, and the differences were statistically significant. There was no significant difference in other scores between the two groups. There was no significant difference in lung function and FeNO level between the two groups.

CONCLUSIONS

SLIT for children with or without allergic asthma or with or without rhinitis has a significant effect, but its effect on children with asthma combined with rhinitis is not superior to that of children with asthma alone.

摘要

背景

过敏性哮喘和过敏性鼻炎是儿童常见的慢性呼吸道疾病。疾病患病率逐年上升。避免接触过敏原、药物治疗和特异性免疫治疗(SIT)是呼吸道过敏性疾病的基本治疗方法。但关于舌下特异性免疫治疗(SLIT)对过敏性哮喘和鼻炎患儿哮喘控制水平、肺功能改善及呼出一氧化氮(FeNO)变化的综合研究较少。

方法

选取71例接受舌下特异性免疫治疗1年及以上的儿童哮喘患者,分为哮喘合并鼻炎组(31例)和单纯哮喘组(40例)。比较两组患者治疗前后的鼻炎症状评分、白天和夜间哮喘症状评分、视觉模拟量表(VAS)评分、药物评分、肺功能及呼出一氧化氮水平(FeNO)。

结果

治疗后,单纯哮喘组的白天症状评分、VAS评分、药物评分及FeNO水平均低于治疗前,肺功能显著改善(P<0.05),而夜间症状评分治疗前后差异无统计学意义(P>0.05)。哮喘合并鼻炎组患儿治疗后的肺功能和FeNO水平低于治疗前,差异有统计学意义(P<0.05)。哮喘合并鼻炎组的鼻炎和VAS评分高于单纯哮喘组,差异有统计学意义。两组其他评分差异无统计学意义。两组肺功能和FeNO水平差异无统计学意义。

结论

SLIT对合并或不合并过敏性哮喘及合并或不合并鼻炎的儿童均有显著效果,但对哮喘合并鼻炎患儿的效果并不优于单纯哮喘患儿。

相似文献

4
[The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].[舌下特异性免疫疗法对儿童变应性鼻炎的疗效]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Apr 5;30(7):546-551. doi: 10.13201/j.issn.1001-1781.2016.07.010.

本文引用的文献

6
House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.屋尘螨舌下免疫治疗小儿变应性哮喘。
Ann Pharmacother. 2018 Oct;52(10):1019-1030. doi: 10.1177/1060028018769443. Epub 2018 Apr 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验